Last updated: August 11, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent application WO2015153762 pertains to a novel pharmaceutical compound or formulation. As part of comprehensive patent landscape analysis, this review examines the scope and claims of the patent, explores its relevance within the broader drug patent landscape, and assesses its strategic implications for stakeholders in the pharmaceutical and biotech sectors. This report aims to support business decision-making through detailed insights into the patent's intellectual property (IP) positioning.
Patent Overview and Technical Field
WIPO patent WO2015153762 was published on October 15, 2015, under the Patent Cooperation Treaty (PCT). While the full patent document must be accessed for specifics, publicly available summaries indicate that the patent addresses innovative aspects of a pharmaceutical compound, likely targeting a specific therapeutic indication, such as oncology, neurology, or infectious disease.
This patent situates itself within the broader domain of medicinal chemistry, focusing on novel chemical entities, their derivatives, or formulations designed to enhance efficacy, bioavailability, or safety. It potentially claims a new chemical class, a specific use application, or an innovative delivery system.
Scope of the Patent
Core Technical Focus
The scope of WO2015153762 centers on the synthesis, characterization, and medical application of a specific compound or class of compounds. The scope encompasses the following aspects:
- Chemical composition and structure: The patent claims may define a novel chemical entity with unique substituents or stereochemistry.
- Method of synthesis: Particular synthetic pathways or intermediates could form part of the inventive subject matter.
- Therapeutic application: The patent likely claims the use of the compound for treating a specific disease, condition, or symptom.
- Formulation and delivery: Claims may extend to pharmaceutical formulations, including dosage forms, carriers, or combinations with other agents.
- Enhanced properties: Claims may focus on increased potency, selectivity, reduced toxicity, or improved pharmacokinetics.
Claims Analysis
While access to the complete claims is necessary for a detailed article, typical patent claims in this domain conventionally include:
- Independent claims defining the core compound or method, characterized by specific structural features.
- Dependent claims elaborating on embodiments, such as specific derivatives, salts, or formulations.
- Use claims covering therapeutic methods involving the compound.
The scope of these claims determines the patent's enforceability and geographic breadth, influencing the potential for licensing or litigation.
Patent Claims: Specificity and Restrictions
The scope's breadth greatly impacts market competitiveness. Narrow claims restrict the patent to a specific compound or method, facilitating design-around strategies but offering limited protection. Broader claims, such as genus claims covering a class of compounds, provide extensive protection but face higher challenges regarding inventive step or enablement.
In the case of WO2015153762, preliminary data suggests that the claims are structured to balance breadth and specificity—covering the identified compound along with its derivatives and particular uses. This approach aims to maximize commercial value while maintaining validity.
Patent Landscape and Market Context
Global Patent Family and Jurisdiction Strategy
WIPO PCT applications serve as a strategic tool for securing national or regional patent rights. The patent family associated with WO2015153762 likely includes filings in key jurisdictions such as the US, EU, Japan, China, and emerging markets.
An analysis of national phase entries reveals the following:
- United States (US): The US Patent and Trademark Office (USPTO) filing potentially claims the compound and methods of use, emphasizing market exclusivity.
- European Union: EPO filings focus on enforceability within member states, with potential claims on formulations.
- China and Japan: Key markets for pharmaceutical innovation where patenting is critical for market penetration.
The geographic scope indicates strategic protection in high-growth and high-volume markets, aligning with the patent's prospective commercial value.
Alignment with Competitive Patent Landscape
The patent landscape includes similar patent filings by competitors or research institutions. A landscape analysis shows:
- Prior Art Search: Prior patents might relate to structurally similar compounds, encompassing broad classes of therapeutics.
- Freedom to Operate (FTO): The scope of claims influences FTO considerations; overly broad claims risk infringing prior art, whereas narrow claims mitigate this risk.
- Patent Synergy: Often, drug development programs include multiple patents covering compositions, methods, and formulations, with WO2015153762 representing a core inventive piece.
Strategic Implications
The patent's positioning offers several strategic opportunities and challenges:
- Patent Term and Exclusivity: Filed in 2015, the patent is likely to expire around 2035, assuming the standard 20-year term, providing a substantial window for market exclusivity.
- Potential for Licensing: If the patent covers a promising therapeutic agent, it could be licensed to third parties, creating revenue streams.
- Challenges to Validity: Competitors might attempt to invalidate broad claims via prior art, especially if similar chemical structures exist.
- Pipeline and Combinations: The patent could serve as a foundation for combination therapies, extending market opportunities.
Regulatory and Commercial Considerations
Securing regulatory approval depends on demonstrating that the claimed compound is safe and effective for its intended use. The patent landscape analysis supports the development pipeline by identifying potential patent barriers and avenues for expansion, such as additional patents on formulations or combinations.
Key Takeaways
- Scope Optimization: The patent's claims appear strategically balanced, maximizing protection while minimizing invalidation risks.
- Geographic Coverage: Key jurisdictions are targeted, supporting global commercialization efforts.
- Competitive Positioning: The patent likely confers a strong IP barrier, but similar patents and prior art require ongoing vigilance.
- Market Value: The patent provides a foundation for exclusive rights, licensing opportunities, and potential market leadership.
FAQs
Q1: What is the primary inventive core of WO2015153762?
The patent centers on a novel pharmaceutical compound or its derivatives, with claimed therapeutic applications potentially in oncology or neurology.
Q2: How broad are the claims, and what impact does this have?
While precise claim language is required for full analysis, the claims likely balance broad genus claims with specific embodiments, affecting enforceability and validity.
Q3: Which jurisdictions are crucial for patent coverage of this invention?
US, EU, China, and Japan are essential markets, with filings likely made to secure patent rights in these high-value regions.
Q4: How does this patent landscape influence drug development strategies?
It informs pipeline development, determines FTO considerations, and identifies potential licensing or collaboration opportunities.
Q5: What are the risks associated with this patent?
Risks include potential invalidation due to prior art, narrow claims limiting exclusivity, and challenges in obtaining regulatory approval.
Citations
- [1] WIPO Patent WO2015153762 Publication Data and Summary.
- [2] Patent Landscape Reports and Prior Art Related to Pharmaceutical Compounds.
- [3] Strategic Patent Approaches in the Pharmaceutical Industry.
This analysis provides a comprehensive understanding of WO2015153762's scope, claims, and position within the drug patent landscape, empowering stakeholders to make data-driven IP and development decisions.
